Urso 250 and Choledocholithiasis - a phase IV clinical study of FDA data

Summary:

Choledocholithiasis is reported as a side effect among people who take Urso 250 (ursodiol), especially for people who are female, 60+ old, also take Furosemide, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Choledocholithiasis when taking Urso 250. It is created by eHealthMe based on reports of 5,057 people who have side effects when taking Urso 250 from the FDA, and is updated regularly.

What is Urso 250?

Urso 250 has active ingredients of ursodiol. eHealthMe is studying from 5,080 Urso 250 users. Check the latest studies of Urso 250.

What is Choledocholithiasis?

Choledocholithiasis (stones in the common bile duct) is found to be associated with 600 drugs and 961 conditions by eHealthMe. Check the latest studies of Choledocholithiasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

5,057 people reported to have side effects when taking Urso 250.
Among them, 20 people (0.4%) have Choledocholithiasis.

Could Urso 250 cause Choledocholithiasis?

Among these 20 people:

What is the gender of people who have Choledocholithiasis when taking Urso 250? *

female: 60 %
male: 40 %

What is the age of people who have Choledocholithiasis when taking Urso 250? *

What are other drugs people take besides Urso 250? *

What are other side effects people have besides Choledocholithiasis? *

Anaemia (lack of blood): 7 people, 35.00%
Oxygen Saturation Decreased: 5 people, 25.00%
Cholangitis (infection of the bile duct): 5 people, 25.00%
Cholangitis Acute (rapid infection of bile duct): 5 people, 25.00%
High Blood Pressure: 5 people, 25.00%
Pancreatitis (inflammation of pancreas): 3 people, 15.00%
Hepatic Function Abnormal: 3 people, 15.00%
Bacteraemia (presence of bacteria in the blood): 3 people, 15.00%
Itching: 3 people, 15.00%
Cellulitis (infection under the skin): 3 people, 15.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 25.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 20.00%
High Blood Cholesterol: 3 people, 15.00%
Upper Respiratory Tract Inflammation: 2 people, 10.00%
Pancreatitis (inflammation of pancreas): 2 people, 10.00%
Hepatitis C: 2 people, 10.00%
Deficiency Anaemia: 2 people, 10.00%
High Blood Pressure: 1 person, 5.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.00%
Biliary Cirrhosis Primary (primary biliary cirrhosis (pbc) is a long-term liver disease that damages the small bile ducts in the liver. the build-up of bile damages the liver): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Urso 250 and have Choledocholithiasis?

- Check whether Choledocholithiasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Urso 250:

Urso 250 (5,080 reports)

Browse all side effects of Urso 250:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Choledocholithiasis:

Choledocholithiasis (600 drugs)

Browse all the conditions that are associated with Choledocholithiasis:

Choledocholithiasis (961 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ursodiol (the active ingredients of Urso 250) and Urso 250 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.